Understand the source comparison
Best Peptides for Bipolar Disorder: Mechanism Comparison
Thymalin T-cell regulation, cytokine modulation Neuroinflammation (IL-6, TNF-α) Subcutaneous 6–8 hours Best evidence for immune normalization in neuroimmune models; requires multi-week administration Cerebrolysin BDNF/NGF mimetic, TrkB activation Hippocampal a
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Thymalin
- T-cell regulation, cytokine modulation
- Neuroinflammation (IL-6, TNF-α)
- Subcutaneous
- 6–8 hours
- Best evidence for immune normalization in neuroimmune models; requires multi-week administration
- Cerebrolysin
- BDNF/NGF mimetic, TrkB activation
- Hippocampal atrophy, synaptic loss
- Intravenous or intramuscular
- 2.5–3 hours
- Strong neuroprotection data in brain injury; limited bipolar-specific trials
- Dihexa
- HGF potentiation, synaptogenesis
- Cognitive impairment, synaptic density
- ~3 hours
- Potent synapse-forming activity; most studied in Alzheimer's models
- P21
- Mitochondrial biogenesis (PGC-1α)
- ATP depletion, oxidative stress
- Intranasal
- 4–6 hours
- Directly addresses mitochondrial dysfunction; intranasal delivery crosses BBB efficiently
- MK 677
- GH/IGF-1 secretion
- Metabolic dysfunction, neuroinflammation
- Oral
- 24 hours
- Indirect neuroprotection via IGF-1; supports metabolic resilience rather than acute symptom control